A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder.
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Major Depressive Disorder
Related studies linked through entity extraction aliases.
The Effectiveness of rTMS in Depressed VA Patients
- Status
- COMPLETED
- Phase
- NA
Safety and Efficacy Study of Citalopram and Lithium for the Treatment of Depressive Mood Disorder Symptoms
- Status
- COMPLETED
- Phase
- PHASE2
Slow-wave Sleep Deprivation in Depression
- Status
- COMPLETED
- Phase
- NA
Effects of Seroquel XR on Sleep Architecture in Patients With Major Depressive Disorder
- Status
- WITHDRAWN
- Phase
- PHASE2
Antidepressant Adherence Via AD_IVR
- Status
- COMPLETED
- Phase
- PHASE3
Biomarkers of Antidepressant Treatment in Adolescents With Major Depression (The Adolescents MDD Study)
- Status
- COMPLETED
- Phase
- PHASE4
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
- Status
- COMPLETED
- Phase
- PHASE3
Epigenetic Regulation of BDNF in Major Depression
- Status
- COMPLETED
- Phase
- N/A
A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE3
Creatine Augmentation in Veterans With SSRI-Resistant Major Depression
- Status
- WITHDRAWN
- Phase
- PHASE4
A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE3
Repetitive Transcranial Magnetic Stimulation for Treating Depression: A Functional Magnetic Resonance Imaging Study
- Status
- TERMINATED
- Phase
- NA
A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder (MDD)
- Status
- COMPLETED
- Phase
- PHASE3
Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD)
- Status
- TERMINATED
- Phase
- PHASE3
A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE3
Transcranial Direct Current Stimulation to Treat Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Follow-up Study of Transcranial Direct Current Stimulation to Treat Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment in Major Depressive Disorder.
- Status
- COMPLETED
- Phase
- PHASE4